参考文献/References:
[1] Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis[J].Am J Cardiol,1972,30(6):595-602.DOI:10.1016/0002-9149(72)90595-4.
[2] Stefania P,Fabio M, Maria P,et al. Diabetic cardiomyopathy:definition, diagnosis, and therapeutic implications[J].Heart Fail Clin,2019,15(3):341-347.DOI:10.1016/j.hfc.2019.02.003.
[3] Monica Z, Josep AV. Contribution of impaired insulin signaling to the pathogenesis of diabetic cardiomyopathy[J].Int J Mol Sci,2019,20(11):2833.DOI:10.3390/ijms20112833.
[4] 刘保岩. 黄芪改善糖尿病心肌损害的临床和实验研究[D]. 山东中医药大学,2013.
[5] 初铭钰. 糖心舒合剂改善糖尿病心肌病的临床及实验研究[D]. 山东中医药大学,2015.
[6] 侯丹丹. 中性粒细胞/淋巴细胞比值与代谢综合征的相关性分析[D]. 宁夏医科大学,2019.
[7] 石灵. 中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值与冠心病合并糖尿病的相关性研究[D].南方医科大学,2018.
[8] Mertoglu C, Gunay M. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus[J].Diabetes Metab Syndr, 2017,11(Suppl 1):S127-S131.DOI:10.1016/j.dsx.2016.12.021.
[9] Shiny A, Bibin YS, Shanthirani CS, et al. Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes[J]. Diabetes Technol Ther,2014,16(8):524-530.DOI:10.1089/dia.2013.0264.
[10] 何圣清, 郑晓斌, 武红梅. NLR与T2DM患者胰岛β细胞第一相分泌的关系[J]. 新医学,2019,50(3):202-205.DOI:10.3969/j.issn.0253-9802.2019.03.011.
[11] 刘媛媛, 凌宏威, 周冬梅, 等. 总胆红素、中性粒细胞与淋巴细胞比值与糖尿病伴冠心病的相关性[J]. 临床与病理杂志, 2019,39(2):324-329.DOI:10.3978/j.issn.2095-6959.2019.02.015.
[12] 鲜廉杰, 丁燕萍. 中性粒细胞与淋巴细胞比值对2型糖尿病合并左室舒张功能不全的相关性分析[J]. 中西医结合心脑血管病杂志, 2018,16(15):2221-2224.DOI:10.12102/j.issn.1672-1349.2018.15.033.
[13] 胡亚娟, 杜艳华, 罗运春. 血小板/淋巴细胞比值对急性心肌梗死合并2型糖尿病患者住院期间的死亡预测价值[J]. 河北医药, 2019,41(7):994-997.DOI:10.3969/j.issn.1002-7386.2019.07.007.
[14] Siedlecki L, Szygula-Jurkiewicz B, Szczurek W, et al. Mortality risk factors in patients with advanced heart failure and diabetes mellitus[J].Kardiol Pol, 2019,77(6):604-609.DOI:10.33963/KP.14813.
[15] Sargin MA,Yassa M,Taymur BD,et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios:are they useful for predicting gestational diabetes mellitus during pregnancy?[J].Ther Clin Risk Manag,2016,12:657-665.DOI:10.2147/TCRM.S104247.
[16] Kanbay M, Solak Y, Unal HU, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease[J].Int Urol Nephrol, 2014,46(8):1619-1625.DOI:10.1007/s11255-014-0730-1.
[17] 杨理惠. 冠心病合并糖尿病患者单核细胞/高密度脂蛋白比率与其冠状动脉狭窄程度的关系[D]. 郑州大学, 2018.
[18] 任尚义. 急性冠脉综合征患者单核细胞计数/高密度脂蛋白胆固醇比值与冠状动脉病变严重程度的相关性分析[D].中国医科大学, 2018.
[19] 黄政辉. 单核细胞与高密度脂蛋白比值和冠状动脉病变严重程度的相关性研究[D]. 宁夏医科大学, 2018.
[20] Gao Y, Zhang Q, Pan T. Relation of monocyte/high-density lipoprotein cholesterol ratio with coronary artery disease in type 2 diabetes mellitus[J].Clin Lab,2018,64(6):901-906.DOI:10.7754/Clin.Lab.2018.171022.
相似文献/References:
[1]李耀辉,侯沃霖,刘芳.肥胖与脂肪组织慢性炎性反应[J].国际内分泌代谢杂志,2016,36(05):342.[doi:10.3760/cma.j.issn.1673-4157.2016.05.15]
Li Yaohui,Hou Wolin,Liu Fang.Obesity and chronic inflammation in adipose tissue[J].International Journal of Endocrinology and Metabolism,2016,36(06):342.[doi:10.3760/cma.j.issn.1673-4157.2016.05.15]
[2]张立弋,常宝成,单春艳,等.SIRT1与糖尿病相关肿瘤的关系[J].国际内分泌代谢杂志,2017,37(06):418.
Zhang Liyi,Chang Baocheng,Shan Chunyan,et al.Association of SIRT1 with diabetes-related tumors[J].International Journal of Endocrinology and Metabolism,2017,37(06):418.